Balancing Innovation and Sustainability
International Journal of Tourism and Hospitality Management in the Digital Age · 06.11.2026 · 8 (1) · 1-17
DOI: 10.4018/ijthmda.427274 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Tourism and Hospitality Management in the Digital Age, erschienen am 06.11.2026. Verfasst von Hilda A. Mwangakala. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
The study examined the dual role of digital technology adoption in tourism growth and the threat of overtourism, highlighting the need to balance digital innovation with sustainable destination management. The findings show that capacity score (-0.70) and visitor volume (+0.69) are the strongest predictors of overtourism risk, while deficient accommodation infrastructure increases risk. Adventure and urban destinations are more susceptible to visitor overflow, whereas beach and nature destinations tend to be more resilient. Furthermore, visitor rating (-0.29) is negatively related to overtourism, indicating that crowding reduces experience quality, while revenue has no significant effect (~0.01). Hence, to ensure sustainability, technologies such as real-time monitoring and algorithmic crowd management are key in addressing overtourism and making destinations sustainable.
Zitieren
APA
Mwangakala, H. A. (2026). Balancing Innovation and Sustainability. International Journal of Tourism and Hospitality Management in the Digital Age, 8(1), 1-17. https://doi.org/10.4018/ijthmda.427274
Vancouver
Mwangakala HA. Balancing Innovation and Sustainability. International Journal of Tourism and Hospitality Management in the Digital Age. 2026;8(1):1-17. doi:10.4018/ijthmda.427274
BibTeX
@article{Mwangakala2026,
author = {Mwangakala, Hilda A.},
title = {Balancing Innovation and Sustainability},
journal = {International Journal of Tourism and Hospitality Management in the Digital Age},
year = {2026},
volume = {8},
number = {1},
pages = {1--17},
doi = {10.4018/ijthmda.427274}
}
EUVIMED